ARCHIVES

In Brief: Peck Joins GenPharm board; Dallas Hospital Selects director For New BMT Program

This article is from The Cancer Letter archive.

Vol. 20 No. 06 | February 11, 1994

Download PDF Visit The Full Archive

Related Articles

Intense Therapies Better Than Lower Dose For AML

November 26, 2004

NCI Board of Scientific Advisors rejects the Institute’s $89 million proteomics research plan.

March 11, 2005

In Brief: Increased Output Can Hold Down High Let Cost, Kligerman says; No More Groups On The Block

March 18, 1977

MSKCC Selects Hartford HealthCare As First Member in Cancer Alliance

September 27, 2013

Stand Up To Cancer Selects Five Groups For “Dream Team” Grants Totaling $73.6M.

May 29, 2009

Upper Endoscopy Most Effective When Performed in 3-Year Intervals

July 27, 2012